New data announced today from four real-world studies shows the impact that cell-based and adjuvanted influenza vaccines can have in reducing the burden of seasonal influenza on hospitals and health systems.
The data from CSL Seqirus were presented at OPTIONS for the Control of Influenza (OPTIONS XI), being held in the United Kingdom.
Read More